Symbol
BMRN on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
9,150,655 shares
Security Ownership %
4.8%
Shares, Excluding Options vs Price
Value, Excluding Options

Capital Research Global Investors ownership in BIOMARIN PHARMACEUTICAL INC Common Stock (BMRN)

13 May 2025 - Capital Research Global Investors has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9,150,655 shares of BIOMARIN PHARMACEUTICAL INC Common Stock (BMRN). This represents 4.8% ownership of the company. In their previous filing dated 13 Feb 2025, Capital Research Global Investors had reported owning 12,991,772 shares, indicating a decrease of +30%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.